• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Kasisomayajula Viswanath Ph.D.

Associate Professor, Society, Human Development and Health, Harvard School of Public Health

Associate Professor of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute

Contact Info

Kasisomayajula Viswanath
Dana-Farber Cancer Institute
44 Binney Street
Boston, MA, 02115
Mailstop: LW703
Phone: 6176322225
Fax: 6175828728
Vish_Viswanath@dfci.harvard.edu

Assistant

Lisa Lowery
Phone: 6176323617
Fax: 6175828728
Lisa_Lowery@dfci.harvard.edu

DF/HCC Program Affiliation

Member, Cancer Risk Reduction Program
Member, Cancer Disparities Program

DF/HCC Associations

Director, Health Communication Core

Research Abstract

Dr. Viswanath’s research interest is in studying the role of communication in health promotion. He has done research in mass mediated health communication in both national and international contexts with a particular focus on communication inequities and health disparities. His research focuses on three related areas. The first area examines the reasons and implications of limited access to information technologies to public health and in the development of strategies to enhance access among the underserved to cancer related health information. A second area studies how news media, specifically journalists play a role in covering medical and health news, the effects of such reportage on knowlege and behaviors of the audience in an attempt to build a bridge betwen the worlds of medicine and journalism. A third area of research examines the effects of news and entertainment on cancer knowledge, attitudes, and behavior in order to use these findings to design effective messages about cancer risk and prevention.

Publications

  • Viswanath K, Kreuter MW. Health Disparities, Communication Inequalities, and eHealth. Am J Prev Med 2007 May; 32(5 Suppl):S131-3
    PMID: 17466818
  • Viswanath K. Science and society: the communications revolution and cancer control. Nat Rev Cancer 2005 Oct; 5(10):828-35
    PMID: 16195753